loadpatents
Patent applications and USPTO patent grants for Johns; Amanda.The latest application filed is for "facilitated comparison of gemstones".
Patent | Date |
---|---|
Facilitated comparison of gemstones Grant 11,288,728 - Caples , et al. March 29, 2 | 2022-03-29 |
Facilitated Comparison Of Gemstones App 20210035178 - Caples; Andrew ;   et al. | 2021-02-04 |
Piperidine compounds for use as orexin receptor antagonist Grant 7,943,645 - Chan , et al. May 17, 2 | 2011-05-17 |
N-aroyl cyclic amine derivatives as orexin receptor antagonists Grant 7,928,124 - Branch , et al. April 19, 2 | 2011-04-19 |
N-aroyl cyclic amine derivatives as orexin receptor antagonists Grant 7,928,125 - Branch , et al. April 19, 2 | 2011-04-19 |
N-aroyl cyclic amines Grant 7,919,507 - Branch , et al. April 5, 2 | 2011-04-05 |
N-aroyl cyclic amine derivatives as orexin receptor antagonists Grant 7,897,618 - Branch , et al. March 1, 2 | 2011-03-01 |
N-aroyl cyclic amine derivatives as orexin receptor antagonists Grant 7,893,090 - Branch , et al. February 22, 2 | 2011-02-22 |
N-aroyl cyclic amines Grant 7,741,329 - Branch , et al. June 22, 2 | 2010-06-22 |
N-aroyl Cyclic Amines App 20090093478 - BRANCH; Clive Leslie ;   et al. | 2009-04-09 |
Piperidine Compounds For Use As Orexin Receptor Antagonist App 20090082390 - CHAN; Wai Ngor ;   et al. | 2009-03-26 |
N-aroyl Cyclic Amine Derivatives As Orexin Receptor Antagonists App 20090036442 - BRANCH; Clive Leslie ;   et al. | 2009-02-05 |
N-aroyl Cyclic Amines App 20090029986 - BRANCH; Clive Leslie ;   et al. | 2009-01-29 |
N-aroyl Cyclic Amine Derivatives As Orexin Receptor Antagonists App 20090012122 - BRANCH; Clive Leslie ;   et al. | 2009-01-08 |
N-aroyl Cyclic Amines App 20090012073 - BRANCH; Clive Leslie ;   et al. | 2009-01-08 |
N-aroyl Cyclic Amine Derivatives As Orexin Receptor Antagonists App 20090012083 - BRANCH; Clive Leslie ;   et al. | 2009-01-08 |
N-aroyl cyclic amine derivatives as orexin receptor antagonists Grant 7,470,710 - Branch , et al. December 30, 2 | 2008-12-30 |
N-aroyl Cyclic Amine Derivatives As Orexin Receptor Antagonists App 20080318944 - BRANCH; Clive Leslie ;   et al. | 2008-12-25 |
Ethylene diamine derivatives and their use as orexin-receptor antagonists Grant 7,468,367 - Coulton , et al. December 23, 2 | 2008-12-23 |
N-aroyl cyclic amines Grant 7,432,270 - Branch , et al. October 7, 2 | 2008-10-07 |
Piperidine compounds for use as orexin receptor antagoinst Grant 7,423,052 - Chan , et al. September 9, 2 | 2008-09-09 |
Benzamide derivatives as antagonists of orexin receptors Grant 7,078,565 - Chan , et al. July 18, 2 | 2006-07-18 |
N-aroyl cyclic amines as orexin receptor antagonists App 20060040937 - Branch; Clive Lesile ;   et al. | 2006-02-23 |
Ethylene diamine derivatives and their use as orexin-receptor antagonists App 20050159421 - Coulton, Steven ;   et al. | 2005-07-21 |
Benzamide derivatives as antagonists of orexin receptors App 20050020584 - Chan, Wai Ngor ;   et al. | 2005-01-27 |
Piperidine compounds for use as orexin receptor antagonist App 20040215014 - Chan, Wai Ngor ;   et al. | 2004-10-28 |
N-aroyl cyclic amine derivatives as orexin receptor antagonists App 20040180887 - Branch, Clive Leslie ;   et al. | 2004-09-16 |
N-aroyl cyclic amines App 20040143115 - Branch, Clive Leslie ;   et al. | 2004-07-22 |
Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists Grant 6,699,879 - Coulton , et al. March 2, 2 | 2004-03-02 |
Phenyl urea and phenyl thiourea derivatives Grant 6,596,730 - Coulton , et al. July 22, 2 | 2003-07-22 |
Substituted tetrahydro isoquinolines as modulators of dopamine D3 receptors Grant 6,274,593 - Johns , et al. August 14, 2 | 2001-08-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.